PubMed:28854065 / 381-570 JSONTXT

{"project":"PubMed_ArguminSci","denotations":[{"id":"T2","span":{"begin":0,"end":189},"obj":"DRI_Background"}],"text":"Patients and Methods In a randomized, double-blind, active-controlled, phase III trial, chemotherapy-naive patients with cancer who were scheduled to receive HEC that contained cisplatin or"}